Survival with Cemiplimab in Recurrent Cervical Cancer
Original Article
K.S. Tewari, B.J. Monk, I. Vergote, A. Miller, A.C.d. Melo, H.-S. Kim, Y.M. Kim, A. Lisyanskaya, V. Samouëlian, D. Lorusso, F. Damian, C.-L. Chang, E.A. Gotovkin, S. Takahashi, D. Ramone, J. Pikiel, B. Maćkowiak-Matejczyk, E.M.G. Alía, N. Colombo, Y. Makarova, D. Rischin, S. Lheureux, K. Hasegawa, K. Fujiwara, J. Li, S. Jamil, V. Jankovic, C.-I. Chen, F. Seebach, D.M. Weinreich, G.D. Yancopoulos, I. Lowy, M. Mathias, M.G. Fury, and A. Oaknin
N Engl J Med 2022;386:544-555
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Saturday, February 10, 2024 - 11:59pm.